Ken James
Fortune : 7 004 $ au 31/05/2026
Fortune : 7 004 $ au 31/05/2026
Ken James is currently Executive Director, Head-Research & Development at Futura Medical Plc since 2016.
Formerly, Mr. James was Director at Futura Medical Developments Ltd. Mr. James was Senior Vice President-Research & Development at Glaxo SmithKline Consumer Healthcare Ltd. from 2006 to 2016.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
FUTURA MEDICAL PLC 0,14 % | 31/12/2025 | 799 501 ( 0,14 % ) | 7 004 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| FUTURA MEDICAL PLC | Directeur Technique/Scientifique/R&D | 16/11/2016 |
| Sociétés | Poste | Fin |
|---|---|---|
Glaxo SmithKline Consumer Healthcare Ltd.
Glaxo SmithKline Consumer Healthcare Ltd. Medical DistributorsDistribution Services Manufactures and supplies over the counter drugs | Directeur Technique/Scientifique/R&D | 01/02/2016 |
Futura Medical Developments Ltd.
Futura Medical Developments Ltd. BiotechnologyHealth Technology Develops biological products | Directeur/Membre du Conseil | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 3 |
|---|---|
Futura Medical Plc
Futura Medical Plc Pharmaceuticals: OtherHealth Technology Produces pharmaceutical products | Health Technology |
Glaxo SmithKline Consumer Healthcare Ltd.
Glaxo SmithKline Consumer Healthcare Ltd. Medical DistributorsDistribution Services Manufactures and supplies over the counter drugs | Distribution Services |
Futura Medical Developments Ltd.
Futura Medical Developments Ltd. BiotechnologyHealth Technology Develops biological products | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national